The "Discovery Issues Unique to Mass-Tort MDLs Summit" is a specialized conference organized by the Rabiej Litigation Law Center, focusing on the unique challenges associated with discovery in mass-tort multidistrict litigations (MDLs). This event brings together judges, attorneys, and experts to discuss and develop best practices and judicial management strategies for handling MDLs effectively.
Key topics covered at the summit include controlling eDiscovery processes, managing electronically stored information (ESI), conducting depositions, handling privilege logs, and utilizing expert testimony. The conference aims to address inefficiencies in current MDL practices and propose new methods for discovery validation, advocating for a shift from exhaustive document production to targeted core discovery.
The summit features panel discussions with notable speakers, such as Bill Johnson, Founder and CEO of TCDI, who shared insights on the use and limitations of artificial intelligence in improving eDiscovery efficiency. These sessions provide attendees with practical knowledge and strategies to navigate the complexities of mass-tort MDLs.
This event is ideal for legal professionals involved in mass-tort litigation, including attorneys, judges, and eDiscovery specialists. Attendees will gain valuable insights into the latest developments and best practices in MDL case management and discovery processes, enhancing their ability to handle complex litigation effectively.
Speakers(1)
Bill Johnson
Founder and CEO at TCDI
Bill Johnson is the Founder and CEO of TCDI, a company specializing in eDiscovery services. He participated as a panelist in the 'Controlling eDiscovery' discussion at the summit, sharing insights on the use and limitations of artificial intelligence in improving eDiscovery efficiency.
Event Details
- Date
- March 21, 2025
- Location
- 🇺🇸 Charleston, United States
- Charleston School of Law
- Audience
- Legal professionals involved in mass-tort litigation, including attorneys, judges, and eDiscovery specialists.